{"id":49331,"date":"2025-04-25T12:13:12","date_gmt":"2025-04-25T12:13:12","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/49331\/"},"modified":"2025-04-25T12:13:12","modified_gmt":"2025-04-25T12:13:12","slug":"pharmacy-and-poisons-board-recalls-substandard-batches-of-paracetamol-augmentin","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/49331\/","title":{"rendered":"Pharmacy and Poisons Board recalls substandard batches of Paracetamol, Augmentin"},"content":{"rendered":"<p style=\"margin-bottom: 1rem; line-height: 1.8;\">The Pharmacy and Poisons Board (PPB) has issued an urgent warning to Kenyans over the presence of substandard and falsified medicines circulating in the market, raising serious public health concerns.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nIn a statement released on Thursday, the Chief Executive Officer, Fred Siyoi, revealed the detection of several compromised batches of injectable Paracetamol, falsified Augmentin drugs, and a product mix-up involving Esomeprazole.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nThe three batches are as follows:<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nParacetamol Injection: Three brands of Paracetamol 1000mg\/100ml injections have exhibited unusual colour changes, prompting fears over their safety and efficacy. The affected products include: Lumidol Injection\u2014Batch Numbers CM4594007, CM4594008, CM4594009, Blink Injection\u2014Batch Numbers C84594005, CS4594004 and Paragen Injection\u2014Batch Number K4290027.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nAll these injections were manufactured by KamlaAmrut Pharmaceutical LLP, India.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nEsomeprazole Pack:\u00a0The Board also confirmed a case of product mix-up involving S-Prazo (Esomeprazole 40mg), Batch No. SPZ404, where a strip of Levofloxacin 500mg tablets was discovered inside a pack meant for Esomeprazole capsules\u2014a potentially harmful error for unsuspecting patients.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nAugmentin: Further investigations have also uncovered falsified Augmentin in the market. The specific products in question are AUGMENTIN 1G \u2013 Batch SGS2 and AUGMENTIN 625mg \u2013 Batch Numbers 8X3K and EU7C.<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\n\u201cThe Pharmacy and Poisons Board urges all pharmaceutical outlets, healthcare providers, and members of the public to immediately stop distributing, selling, issuing, or using the affected product batches. Anyone in possession of the flagged drugs is advised to return them to the nearest healthcare facility or supplier.\u201d<\/p>\n<p style=\"margin-bottom: 1rem; line-height: 1.8;\">&#13;<br \/>\nThe Board encourages Kenyans to report any suspected cases of substandard medicines or adverse drug reactions to nearby health facilities or directly to the PPB through its reporting channels.<\/p>\n","protected":false},"excerpt":{"rendered":"The Pharmacy and Poisons Board (PPB) has issued an urgent warning to Kenyans over the presence of substandard&hellip;\n","protected":false},"author":2,"featured_media":49332,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[26686,26688,13,105,4326,26687,26685,16,15],"class_list":{"0":"post-49331","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-augmentin","9":"tag-fred-siyoi","10":"tag-headlines","11":"tag-health","12":"tag-medication","13":"tag-pharmacy-and-poisons-board","14":"tag-pharmacy-and-poisons-board-recalls-substandard-batches-of-paracetamol","15":"tag-uk","16":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114398547459630743","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/49331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=49331"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/49331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/49332"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=49331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=49331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=49331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}